Using test dose challenges to restore essential therapy in patients with idiopathic anaphylaxis and pharmacophobia: report of a patient with idiopathic anaphylaxis and statin phobia.

Allergy and asthma proceedings : the official journal of regional and state allergy societies

Volumn 22, Issue 5, 2001, Pages 303-309

  Mastrovich, J D ^a   Patterson, R ^a   Davison, R ^a   Harris, K E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PYRROLE DERIVATIVE;

ANAPHYLAXIS; ARTICLE; CASE REPORT; DOSE RESPONSE; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; MIDDLE AGED; PHOBIA;

ANAPHYLAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LOVASTATIN; MIDDLE AGED; PHOBIC DISORDERS; PYRROLES;

EID: 0035462088     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)